Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
Efficacy and Safety of Empagliflozin in NODAT
ClinicalTrials.gov study NCT03642184. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Empagliflozin Versus Vildagliptin in CAD Patients With T2DM
ClinicalTrials.gov study NCT06313008. IPD Sharing: NO. Countries: 1. Publications: 4.
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
ClinicalTrials.gov study NCT05164263. IPD Sharing: NO. Countries: 5. Publications: 2.
Renohemodynamic Effects of Combined empagliflOzin and LosARtan
ClinicalTrials.gov study NCT04238702. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Empagliflozin and Cardiac Remodelling in People Without Diabetes
ClinicalTrials.gov study NCT04461041. IPD Sharing: NO. Countries: 2. Publications: 1.
Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
ClinicalTrials.gov study NCT05417880. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02686476. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
ClinicalTrials.gov study NCT03027960. IPD Sharing: NO. Countries: 1. Publications: 2.
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
ClinicalTrials.gov study NCT06249945. IPD Sharing: NO. Countries: 1. Publications: 22.
A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure
ClinicalTrials.gov study NCT03152552. IPD Sharing: UNDECIDED. Countries: 24. Publications: 0.
EMPRA (EMPagliflozin and RAs in Kidney Disease)
ClinicalTrials.gov study NCT03078101. IPD Sharing: NO. Countries: 1. Publications: 1.
Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT04203927. IPD Sharing: Not stated. Countries: 1. Publications: 16.
Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Met
ClinicalTrials.gov study NCT03351478. IPD Sharing: YES. Countries: 12. Publications: 0.
Benefits of Empagliflozin in Patients With Heart Failure and Reduced Ejection Fraction Without Diabetes Mellitus
ClinicalTrials.gov study NCT06632561. IPD Sharing: YES. Countries: 1. Publications: 1.
The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate
ClinicalTrials.gov study NCT06641128. IPD Sharing: NO. Countries: 1. Publications: 8.
" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "
ClinicalTrials.gov study NCT05580510. IPD Sharing: NO. Countries: 1. Publications: 11.
Figure 4 from: Obaid KA, Fawzi HA (2024) Evaluation of empagliflozin efficacy as a promising anti-aging treatment in mice: In-vivo study. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e116184
Figure 4 Cross-sections of heart tissue of mice. A: In mice received normal saline only (G1); B: In mice received DGAL only (G2); C: In mice received DGAL and EMP 1 mg/kg after the end of induction (G4) (Olympus BX51microscpose and a software DP controller X40).
Supplemetary material- Apelin and Copeptin Levels in Patients With Chronic SIAD Treated With Empagliflozin
Open the record for dataset details and reuse information.
Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Con
ClinicalTrials.gov study NCT01451775. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.
ClinicalTrials.gov study NCT07363707. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.